Averhealth acquires Vermont-based healthcare company Aspenti

Averhealth, a substance use monitoring and treatment services provider, with the backing of Five Arrows Capital Partners, has acquired Vermont-based healthcare company Aspenti for an undisclosed price.

Aspenti is a specialist in substance use monitoring and care coordination services for patients of physicians, healthcare systems, and treatment centers.

Jason Herzog – CEO of Averhealth said: “The acquisition of Aspenti broadens Averhealth’s referral base to include physicians, treatment centers and healthcare systems.

“Aspenti’s social mission of promoting positive change, improving well-being and creating a better world perfectly aligns with Averhealth’s mission of reclaiming lives, uniting families and strengthening communities. This is a perfect fit for us as we advance our goal of improving patient outcomes for those struggling with substance use disorder.”

Averhealth acquires Vermont-based healthcare company Aspenti

Established in 2017, Aspenti offers healthcare services and diagnostic testing for addressing population health for substance use management.

Chris Powell – CEO of Aspenti said: “With Averhealth acquiring Aspenti, it fosters long-term sustainable growth for our colleagues, patients and partners. Both companies are dedicated to delivering continuity of care and exemplary customer service that we both value.

“As a purpose driven company, Averhealth’s mission, vision, and values will foster and continue Aspenti’s work of being a steward of change in substance use management and the greater healthcare industry.”